Results 1 to 10 of about 29,909 (228)

Effectiveness of 0.1% triamcinolone acetonide compared with those of other therapies for minor recurrent aphthous stomatitis: a systematic review and meta-analysis of randomized controlled trials [PDF]

open access: yesBMC Oral Health
Background Recurrent aphthous stomatitis (RAS) is a common oral mucosal condition affecting over 2.5 billion people worldwide. Although 0.1% triamcinolone acetonide is a standard treatment, its comparative efficacy remains uncertain.
Anas Saeed Al-Zaghruri   +8 more
doaj   +2 more sources

Combination Hyaluronidase and Triamcinolone Acetonide Enzymatic Injections for Treatment of Ledderhose Disease: A Novel Technique and Case Series [PDF]

open access: yesClinics and Practice
Background: Ledderhose Disease, or plantar fibromatosis, is a fibroproliferative disorder affecting the plantar fascia with limited effective treatment options.
Paul Carroll   +5 more
doaj   +2 more sources

Evaluation of the efficacy of combination therapy in the treatment of fungal otitis externa [PDF]

open access: yesScientific Reports
Assess the efficacy of sodium bicarbonate solution and Triamcinolone Acetonide and Econazole Nitrate Cream combination therapy in the treatment of fungal otitis externa.
Yan Li, Guangping Bai, Yonggang Jin
doaj   +2 more sources

Resistance band training after triamcinolone acetonide injection for subacromial bursitis: A randomized clinical trial

open access: yesJournal of Rehabilitation Medicine, 2021
Objective: To investigate the effect of progressive resistance training using resistance (elastic) bands on subacromial bursitis following triamcinolone acetonide injection. Design: Randomized clinical trial.
Pengfei Zhu   +5 more
doaj   +1 more source

Triamcinolone acetonide acetate [PDF]

open access: yesActa Crystallographica Section E Structure Reports Online, 2011
IN THE CRYSTAL STRUCTURE OF THE TITLE COMPOUND [SYSTEMATIC NAME: 2-(4b-fluoro-5-hy-droxy-4a,6a,8,8-tetra-methyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodeca-hydro-7,9-dioxa-penta-leno[2,1-a]phenanthren-6b-yl)-2-oxoethyl acetate], C(26)H(33)FO(7), the mol-ecules are connected by inter-molecular O-H⋯O hydrogen bonds into an infinite supra-molecular ...
Xiao Lu   +3 more
openaire   +3 more sources

Is a Decreased Nitric Oxide Concentration after Triamcinolone Acetonide Intravitreal Injection One of the Reasons for Intraocular Pressure Rise?

open access: yesActa Clinica Croatica, 2022
Diabetic macular edema is the most common cause of vision loss in patients affected by diabetes mellitus. For eyes with persistent retinal thickening despite anti-VEGF therapy, treatment with intravitreal triamcinolone may be considered, especially in ...
Nenad Petrović   +6 more
doaj   +1 more source

(–)-5-[(4R,5R)-5-(Benzyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-4,7-dihydro-1,3-dioxepine

open access: yesMolbank, 2010
The synthesis of(–)-5-[(4R,5R)-5-(benzyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-4,7-dihydro-1,3-dioxepine is reported. Product characterization was carried out by IR, 1H NMR, 13C NMR, MS, elemental analysis and optical rotation.
Carlos R. Carreras   +5 more
doaj   +1 more source

Corticosteroid implants for chronic non-infectious uveitis. [PDF]

open access: yes, 2016
BACKGROUND: Uveitis is a term used to describe a heterogeneous group of intraocular inflammatory diseases of the anterior, intermediate, and posterior uveal tract (iris, ciliary body, choroid).
Brady, Christopher J   +7 more
core   +2 more sources

Synthesis and Structure-Activity Relationships of Novel Ecdysteroid Dioxolanes as MDR Modulators in Cancer

open access: yesMolecules, 2013
Ecdysteroids, molting hormones of insects, can exert several mild, non-hormonal bioactivities in mammals, including humans. In a previous study, we have found a significant effect of certain derivatives on the ABCB1 transporter mediated multi-drug ...
Ana Martins   +8 more
doaj   +1 more source

Widening use of dexamethasone implant for the treatment of macular edema [PDF]

open access: yes, 2017
Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis.
Avitabile T.   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy